Literature DB >> 15073838

The use of controlled analgesics in a general population (15-59 years)--the influence of age, gender, morbidity, lifestyle and sociodemographic factors.

A E Eggen1.   

Abstract

The use of controlled analgesics (codeine, buprenorphine and pentazocine preparations) was studied through drugs dispensed (prescriptions) over a one-year period in the municipality of Tromsø, Norway. Drug use was linked to information from the Tromsø Health Survey, a cross-sectional survey where the population was invited to a health screening. The study sample comprised 9640 women and 9141 men between 15 and 59 years of age. About 9% of the population had obtained one or more prescriptions. Combined codeine preparations dominated, and the average amount purchased was 25 defined daily doses/year. The use was mainly sporadic, but regular use did occur. Low self-evaluated health, headache suffering and former use of analgesics and psychotropics were the most significant predictors. However, daily smoking and low education level were also significant predictors. Drug use increased significantly with age, but only a minor gender difference was observed. After adjustment for differences in health problems the gender difference became insignificant.

Entities:  

Year:  1996        PMID: 15073838     DOI: 10.1002/(SICI)1099-1557(199603)5:2<101::AID-PDS202>3.0.CO;2-K

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  3 in total

1.  Use of drugs subject to controlled prescriptions: a retrospective analysis.

Authors:  Dilek Demircan; Sinem Ezgi Gülmez; Başak Dönertaş; Ibrahim Topcu; Hüseyin Yılmaz; Kemal Berkman; Ahmet Akıcı
Journal:  Balkan Med J       Date:  2013-03-01       Impact factor: 2.021

2.  Persistent analgesic use and the association with chronic pain and other risk factors in the population-a longitudinal study from the Tromsø Study and the Norwegian Prescription Database.

Authors:  Per-Jostein Samuelsen; Kristian Svendsen; Tom Wilsgaard; Audun Stubhaug; Christopher Sivert Nielsen; Anne Elise Eggen
Journal:  Eur J Clin Pharmacol       Date:  2016-04-12       Impact factor: 2.953

3.  Analgesic use in a Norwegian general population: change over time and high-risk use--The Tromsø Study.

Authors:  Per-Jostein Samuelsen; Lars Slørdal; Ulla Dorte Mathisen; Anne Elise Eggen
Journal:  BMC Pharmacol Toxicol       Date:  2015-06-06       Impact factor: 2.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.